| SSO Study Start-Up Manager |
London (The Westworks) |
United Kingdom |
Development |
Innovative Medicines |
Research & Development |
Paź 16, 2024 |
| Director, Development Unit Management |
Basel (City) |
Switzerland |
Development |
Innovative Medicines |
Research & Development |
Paź 16, 2024 |
| GCP Inspection Project Manager |
London (The Westworks) |
United Kingdom |
Development |
Innovative Medicines |
Quality |
Paź 16, 2024 |
| Senior Expert Science & Technology, Analytical Development |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
Paź 16, 2024 |
| Submission Readiness Document Manager |
Basel (City) |
Switzerland |
Development |
Innovative Medicines |
Research & Development |
Paź 02, 2024 |
| Clinical Document Management - Business Migrations Manager |
Dublin (Novartis Corporate Center (NOCC)) |
Ireland |
Development |
Innovative Medicines |
Research & Development |
Paź 02, 2024 |
| Senior Clinical Research Associate |
Field Non-Sales (USA) |
USA |
Development |
Innovative Medicines |
Research & Development |
Paź 02, 2024 |
| Senior Clinical Data Scientist |
Dublin (Novartis Corporate Center (NOCC)) |
Ireland |
Development |
Innovative Medicines |
Research & Development |
Paź 11, 2024 |
| Global QMS RDQ Specialist |
Hyderabad (Office) |
India |
Development |
Innovative Medicines |
Quality |
Paź 13, 2024 |
| Associate Director, Vendor Alliance Lead |
London (The Westworks) |
United Kingdom |
Development |
Innovative Medicines |
Research & Development |
Paź 14, 2024 |
| Senior Global Program Regulatory Manager |
London (The Westworks) |
United Kingdom |
Development |
Innovative Medicines |
Research & Development |
Paź 14, 2024 |
| Global Program Regulatory Manager |
London (The Westworks) |
United Kingdom |
Development |
Innovative Medicines |
Research & Development |
Paź 14, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Paź 09, 2024 |
| Clinical Research Associate |
Field Force (Italy) |
Italy |
Development |
Innovative Medicines |
Research & Development |
Paź 16, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Paź 09, 2024 |
| Gerente de Operações Estratégicas e Compliance Jr. |
Santo Amaro |
Brazil |
Development |
Innovative Medicines |
Research & Development |
Paź 18, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Paź 09, 2024 |
| Feasibility Manager |
INSURGENTES |
Mexico |
Development |
Innovative Medicines |
Research & Development |
Paź 16, 2024 |
| Patient Safety Manager |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
Development |
Innovative Medicines |
Research & Development |
Wrz 04, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Paź 09, 2024 |
| Head, Clinical Development Business Solutions |
Basel (City) |
Switzerland |
Development |
Innovative Medicines |
Research & Development |
Paź 10, 2024 |
| Central Integrated Scientific Review Committee Lead |
Dublin (Novartis Corporate Center (NOCC)) |
Ireland |
Development |
Innovative Medicines |
Research & Development |
Paź 14, 2024 |
| Associate Director, Clinical Processes & Solutions |
Dublin (Novartis Corporate Center (NOCC)) |
Ireland |
Development |
Innovative Medicines |
Research & Development |
Paź 14, 2024 |
| Head Clinical Development Business Solutions |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
Paź 18, 2024 |
| Clinical Biospecimen Senior Scientist |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Wrz 03, 2024 |
| Senior Statistical Programmer |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Lip 18, 2024 |
| Study Leader |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Wrz 05, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Paź 09, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Paź 09, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Paź 09, 2024 |
| Expert Science & Technology |
Changshu (Jiangsu Province) |
China |
Development |
Innovative Medicines |
Research & Development |
Wrz 03, 2024 |
| Regulatory Affairs Manager |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Wrz 01, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Paź 09, 2024 |
| Ethics, Risk & Compliance Manager |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Sie 22, 2024 |
| Associate Director, Data Privacy, Digital & AI |
East Hanover |
USA |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
Wrz 04, 2024 |
| Associate Director ERC Risk&Operations, Corporate Functions |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
Sie 29, 2024 |
| Sr Manager/Manager-Monitoring |
Shanghai (Shanghai) |
China |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Lip 18, 2024 |
| Manager- Data Privacy Review and Remediation |
Telangana |
India |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
Paź 10, 2024 |
| Head DPDAI China |
Shanghai (Shanghai) |
China |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Paź 14, 2024 |
| Manager- Data Privacy Review and Remediation |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
Paź 14, 2024 |
| Risk & Assurance Manager |
Mumbai (Head Office) |
India |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Paź 16, 2024 |
| Country ERC Head, India |
Mumbai (Office) |
India |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Paź 16, 2024 |
| Associate Director - Risk & Assurance, EUROPE |
Prague |
Czech Republic |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Paź 11, 2024 |
| ERP Assurance Senior Consultant-2 |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
Sie 20, 2024 |
| Business Planning and Analysis Manager, Novartis Technical Operations |
INSURGENTES |
Mexico |
Finance |
Innovative Medicines |
Audit & Finance |
Sie 22, 2024 |
| R2R Specialist - Inventory |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Lip 28, 2024 |
| BPA Planning Process, RLT |
Baarle Nassau |
Netherlands |
Finance |
Innovative Medicines |
Audit & Finance |
Sie 05, 2024 |
| BPA & R2R Analyst |
Amsterdam |
Netherlands |
Finance |
Innovative Medicines |
Audit & Finance |
Wrz 04, 2024 |
| R2R Senior Specialist |
Bucuresti |
Romania |
Finance |
CTS |
Audit & Finance |
Wrz 05, 2024 |
| Associate Director, US Federal and State Tax Reporting |
East Hanover |
USA |
Finance |
Corporate |
Audit & Finance |
Wrz 06, 2024 |